Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
SCTR regulates cell cycle-related genes toward anti-proliferation in normal breast cells while having
Seongeun Kang1, Byungtak Kim1, Han-Sung Kang2
1Department of Life Science, Dongguk University-Seoul, Goyang, Republic of Korea.
Abstract:
Secretin receptor (SCTR), the G-protein coupled receptor (GPCR) for secretin, has been observed to be upregulated in a few tumor types while downregulated in others, promoting or suppressing the proliferation of tumor cells, respectively. However, little is known about the molecular regulatory mechanism of dysregulation in cancer. In the present study, an analysis of the biological pathways affected by methylation in breast cancer using the methylome databases revealed that GPCRs played a major part in the affected pathway. SCTR, one of the dysregulated GPCRs, showed hypermethylation (p<0.01) and downregulation (p<0.05) in breast cancer tissues. Pathway analysis after the downregulation of SCTR by siRNA in MCF-10A cells identified the G2/M stage checkpoint as the top-scored pathway. Cell cycle-related genes were all upregulated or downregulated suppressing cell proliferation. However, the overexpression of SCTR in MCF-7 cells led to a 35% increase of the cell proliferation index and 2.1-fold increase of cellular migration. Our findings indicate that SCTR suppresses the proliferation of normal breast cells, while the gene stimulates the proliferation and migration of cancer cells being downregulated by promoter methylation.
Insights
Secretin receptor (SCTR) methylation downregulates SCTR in breast cancer, suppressing normal cell growth. However, SCTR overexpression stimulates cancer cell proliferation and migration.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Secretin receptor (SCTR), a G-protein coupled receptor (GPCR), exhibits varied expression in tumors, influencing cancer cell proliferation.
- The molecular mechanisms behind SCTR dysregulation in cancer remain largely unelucidated.
Purpose of the Study:
- To investigate the role of SCTR methylation in breast cancer and its impact on cell proliferation and migration.
- To understand the regulatory mechanisms of SCTR dysregulation in breast cancer.
Main Methods:
- Methylome database analysis in breast cancer to identify affected pathways.
- siRNA-mediated downregulation of SCTR in MCF-10A cells followed by pathway analysis.
- Overexpression of SCTR in MCF-7 cells to assess effects on proliferation and migration.
Main Results:
- SCTR demonstrated hypermethylation and downregulation in breast cancer tissues (p<0.01 and p<0.05, respectively).
- Downregulation of SCTR in normal breast cells (MCF-10A) affected the G2/M stage checkpoint and cell cycle genes, suppressing proliferation.
- SCTR overexpression in breast cancer cells (MCF-7) increased proliferation by 35% and migration by 2.1-fold.
Conclusions:
- SCTR promoter methylation leads to its downregulation in breast cancer, which suppresses normal breast cell proliferation.
- Conversely, SCTR stimulates proliferation and migration in breast cancer cells, suggesting a dual role dependent on its expression level and cellular context.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

